Shriram Revankar - 15 May 2026 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 May 2026, 17:31:04 UTC
Prior SEC filing
17 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Shriram Revankar

Key filing fact

Shriram Revankar filed Form 4 for Dolby Laboratories, Inc. (DLB) on 19 May 2026.

Key facts

  • This page summarizes Shriram Revankar's Form 4 filing for Dolby Laboratories, Inc. (DLB).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 May 2026, 17:31.

Change

  • Previous filing in this sequence was filed on 17 Feb 2026.
  • Current net transaction value: -$164,700.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001928994 Primary reporting owner

Revankar Shriram

Relationship
SVP, Advanced Technology Group
Address
C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Shriram Revankar
Signature date
19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DLB transaction

Class A Common Stock

Sale

Transaction value
$164,700
Shares
-3,000
Change %
-3.6%
Price
$54.90
Shares after
80,603
Date
15 May 2026
Ownership
Direct
Footnotes
F1, F2, F3
DLB transaction

Class A Common Stock

Tax liability

Transaction value
Shares
-4,329
Change %
-5.4%
Price
$54.21*
Shares after
76,274
Date
18 May 2026
Ownership
Direct
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The shares were sold pursuant to a 10b5-1 trading plan adopted on August 22, 2025.

Footnote F2

Shares held following the reported transactions include 59,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

Footnote F3

Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.

Footnote F4

In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units.

Footnote F5

Shares held following the reported transactions include 46,938 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .